Genetic markers of abdominal obesity and weight loss after gastric bypass surgery

PLoS One. 2021 May 28;16(5):e0252525. doi: 10.1371/journal.pone.0252525. eCollection 2021.

Abstract

Background: Weight loss after bariatric surgery varies widely between individuals, partly due to genetic differences. In addition, genetic determinants of abdominal obesity have been shown to attenuate weight loss after dietary intervention with special attention paid to the rs1358980-T risk allele in the VEGFA locus. Here we aimed to test if updated genetic risk scores (GRSs) for adiposity measures and the rs1358980-T risk allele are linked with weight loss following gastric bypass surgery.

Methods: Five hundred seventy six patients with morbid obesity underwent Roux-en-Y gastric bypass. A GRS for BMI and a GRS for waist-hip-ratio adjusted for BMI (proxy for abdominal obesity), respectively, were constructed. All patients were genotyped for the rs1358980-T risk allele. Associations between the genetic determinants and weight loss after bariatric surgery were evaluated.

Results: The GRS for BMI was not associated with weight loss (β = -2.0 kg/100 risk alleles, 95% CI -7.5 to 3.3, p = 0.45). Even though the GRS for abdominal obesity was associated with an attenuated weight loss response adjusted for age, sex and center (β = -14.6 kg/100 risk alleles, 95% CI -25.4 to -3.8, p = 0.008), it was not significantly associated with weight loss after adjustment for baseline BMI (β = -7.9 kg/100 risk alleles, 95% CI -17.5 to 1.6, p = 0.11). Similarly, the rs1358980-T risk allele was not significantly associated with weight loss (β = -0.8 kg/risk allele, 95% CI -2.2 to 0.6, p = 0.25).

Discussion: GRSs for adiposity derived from large meta-analyses and the rs1358980-T risk allele in the VEGFA locus did not predict weight loss after gastric bypass surgery. The association between a GRS for abdominal obesity and the response to bariatric surgery may be dependent on the association between the GRS and baseline BMI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Bariatric Surgery
  • Body Mass Index
  • Female
  • Genetic Markers
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Obesity, Abdominal / genetics*
  • Obesity, Abdominal / pathology
  • Vascular Endothelial Growth Factor A / genetics
  • Waist-Hip Ratio
  • Weight Loss / genetics*

Substances

  • Genetic Markers
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A

Grants and funding

This study was funded by a grant from The Ministry of Higher Education and Science The UNIK Initiative: Food, Fitness & Pharma for Health and Disease (TH, http://ufm.dk). The project was also supported with funds from the Challenge Programme MicrobLiver (Grant No. NNF15OC0016692) (TH, http://challenge.novonordiskfoundation.com). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research centre at the University of Copenhagen and is partly funded by an unrestricted donation from the Novo Nordisk Foundation.